FSSAI suspends Dior Pharmaceuticals’ nutraceutical manufacturing licence
FSSAI has suspended Dior Pharmaceuticals’ manufacturing licence at its Punjab nutraceutical plant after finding serious GMP, hygiene, food-safety and traceability lapses. Operations must remain halted until deficiencies are rectified and compliance is restored.
FSSAI suspended Dior Pharmaceuticals' nutraceutical manufacturing licence in Punjab after finding serious GMP, hygiene, food-safety and traceability failures. The company must halt operations until deficiencies are rectified and regulatory compliance is restored.